B
Bruce H. Brundage
Researcher at UCLA Medical Center
Publications - 190
Citations - 26880
Bruce H. Brundage is an academic researcher from UCLA Medical Center. The author has contributed to research in topics: Pulmonary hypertension & Coronary artery disease. The author has an hindex of 64, co-authored 190 publications receiving 26135 citations. Previous affiliations of Bruce H. Brundage include United States Department of Veterans Affairs & University of California, Los Angeles.
Papers
More filters
Journal ArticleDOI
Survival in Patients with Primary Pulmonary Hypertension: Results from a National Prospective Registry
Gilbert E. D'Alonzo,Robyn J. Barst,Stephen M. Ayres,Edward H. Bergofsky,Bruce H. Brundage,Katherine M. Detre,Alfred P. Fishman,Roberta M. Goldring,Berton M. Groves,Janet T. Kernis,Paul S. Levy,Giuseppe G. Pietra,Lynne Reid,John T. Reeves,Stuart Rich,Carol E. Vreim,George W. Williams,Margaret Wu +17 more
TL;DR: Mortality was most closely associated with right ventricular hemodynamic function and can be characterized by means of an equation using three variables: mean pulmonary artery pressure, mean right atrial pressure, and cardiac index.
Journal ArticleDOI
A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension
Robyn J. Barst,Lewis J. Rubin,Walker Long,Michael D. McGoon,Stuart Rich,David B. Badesch,Bertron M. Groves,Victor F. Tapson,Robert C. Bourge,Bruce H. Brundage,Spencer K. Koerner,David Langleben,Cesar A. Keller,Srinivas Murali,Barry F. Uretsky,Linda M. Clayton,Maria M. Jöbsis,Shelmer D. Blackburn,Denise Shortino,James W. Crow +19 more
TL;DR: As compared with conventional therapy, the continuous intravenous infusion of epoprostenol produced symptomatic and hemodynamic improvement, as well as improved survival in patients with severe primary pulmonary hypertension.
Journal ArticleDOI
Primary pulmonary hypertension: a national prospective study
Stuart Rich,D R Dantzker,S M Ayres,Edward H. Bergofsky,Bruce H. Brundage,Katherine M. Detre,Alfred P. Fishman,Roberta M. Goldring,Bertron M. Groves,Spencer K. Koerner +9 more
TL;DR: Although no deaths or sustained morbid events occurred during the diagnostic evaluation of the patients, the typically long interval from initial symptoms to diagnosis emphasizes the need to develop strategies to make the diagnosis earlier.
Journal ArticleDOI
ACCF/AHA 2007 Clinical Expert Consensus Document on Coronary Artery Calcium Scoring By Computed Tomography in Global Cardiovascular Risk Assessment and in Evaluation of Patients With Chest Pain
Philip Greenland,Robert O. Bonow,Bruce H. Brundage,Matthew J. Budoff,Mark J. Eisenberg,Scott M. Grundy,Michael S. Lauer,Wendy S. Post,Paolo Raggi,Rita F. Redberg,George P. Rodgers,Leslee J. Shaw,Allen J. Taylor,William S. Weintraub,Robert A. Harrington,Jonathan Abrams,Jeffrey L. Anderson,Eric R. Bates,Cindy L. Grines,Mark A. Hlatky,Robert C. Lichtenberg,Jonathan R. Lindner,Gerald M. Pohost,Richard S. Schofield,Samuel J. Shubrooks,James H. Stein,Cynthia M. Tracy,Robert A. Vogel,Deborah J. Wesley +28 more
TL;DR: The CAC Measurement Method helps clarify the role of risk assessment in Cardiovascular Medicine and current approaches to Global Risk Assessment and to match the intensity of intervention with the severity of risk.
Journal ArticleDOI
Coronary artery calcification: pathophysiology, epidemiology, imaging methods, and clinical implications. A statement for health professionals from the American Heart Association. Writing Group.
Lewis Wexler,Bruce H. Brundage,John R. Crouse,Robert Detrano,Valentin Fuster,Jamshid Maddahi,J. A. Rumberger,William Stanford,Richard D. White,Kathryn A. Taubert +9 more
TL;DR: It is shown that plaques with microscopic evidence of mineralization are larger and associated with larger coronary arteries than are plaques or arteries without calcification, which indicates that calcification is an active process and not simply a passive precipitation of calcium phosphate crystals, as once thought.